--- title: Simsen Diagnostics' hospital laboratory solution description: Simsen Diagnostics solution for hospital laboratories. image: https://simsendiagnostics.com/hubfs/simsen-contact-scaled.jpg --- [Skip to the main content.](https://simsendiagnostics.com/news/simsen-diagnostics-hospital-laboratory-solution#main-content) [![Simsen logotype](https://simsendiagnostics.com/hs-fs/hubfs/SD_logo%20medium-2.png?width=588&height=164&name=SD_logo%20medium-2.png "Simsen logotype")](https://simsendiagnostics.com) [![Simsen logotype](https://simsendiagnostics.com/hs-fs/hubfs/SD_logo%20medium-2.png?width=588&height=164&name=SD_logo%20medium-2.png "Simsen logotype")](https://simsendiagnostics.com) - [PLATFORM](https://simsendiagnostics.com/platform) - [Why Simsen](https://simsendiagnostics.com/why-simsen) - [Our technology](https://simsendiagnostics.com/platform-our-technology) - [Methodology](https://simsendiagnostics.com/platform-methodology) - [Find your approach](https://simsendiagnostics.com/find-your-approach) - [Delivered your way](https://simsendiagnostics.com/both-delivery-models) - [Solutions](https://simsendiagnostics.com/solutions-overview) - [EVIDENCE](https://simsendiagnostics.com/evidence-hub) - [Publications](https://simsendiagnostics.com/evidence-publications) - [Paediatric solid tumours](https://simsendiagnostics.com/evidence-paediatric-solid-tumours) - [CNS tumours & CSF ctDNA](https://simsendiagnostics.com/evidence-cns-csf-ctdna) - [White papers](https://simsendiagnostics.com/evidence-white-paper-ctdna-trials) - [COMPANY](https://simsendiagnostics.com/company-about) - [About us](https://simsendiagnostics.com/company-about) - [Team](https://simsendiagnostics.com/company-team) - [Contact us](https://simsendiagnostics.com/company-contact) - [News](https://simsendiagnostics.com/news) - [RESOURCES](https://simsendiagnostics.com/resources-hub) - [Sample collection guides](https://simsendiagnostics.com/resources-sample-collection-guides) - [Baseline kit guide](https://simsendiagnostics.com/baseline-collection-kit) - [Follow-up kit guide](https://simsendiagnostics.com/resources-followup-collection-kit) Search [![Request a conversation](https://hubspot-no-cache-eu1-prod.s3.amazonaws.com/cta/default/25734893/interactive-412216133822.png)](https://simsendiagnostics.com/hs/cta/wi/redirect?encryptedPayload=AVxigLLG5ONwtY8aabjajA53G5FpNPC9qYDK5972KMBk84GXBY9RLmqhSV0NQYrYQOphdig7vCRxC1dwxX99nhplMSzr4Rl7TowdJBPNK5Rbjr6EYCI4X1%2BzjIyTaH%2B8j6Y96k7SpH6DyB%2FYMEupbDCjC7a0QrnfZewrMdbWV6ELoDdWm37w6LAmoVXDc7K9QbnoNh%2BDLie1&webInteractiveContentId=412216133822&portalId=25734893) Toggle Menu Search Toggle Menu [![Request a conversation](https://hubspot-no-cache-eu1-prod.s3.amazonaws.com/cta/default/25734893/interactive-412216133822.png)](https://simsendiagnostics.com/hs/cta/wi/redirect?encryptedPayload=AVxigLLG5ONwtY8aabjajA53G5FpNPC9qYDK5972KMBk84GXBY9RLmqhSV0NQYrYQOphdig7vCRxC1dwxX99nhplMSzr4Rl7TowdJBPNK5Rbjr6EYCI4X1%2BzjIyTaH%2B8j6Y96k7SpH6DyB%2FYMEupbDCjC7a0QrnfZewrMdbWV6ELoDdWm37w6LAmoVXDc7K9QbnoNh%2BDLie1&webInteractiveContentId=412216133822&portalId=25734893) - [PLATFORM](https://simsendiagnostics.com/platform) - [Why Simsen](https://simsendiagnostics.com/why-simsen) - [Our technology](https://simsendiagnostics.com/platform-our-technology) - [Methodology](https://simsendiagnostics.com/platform-methodology) - [Find your approach](https://simsendiagnostics.com/find-your-approach) - [Delivered your way](https://simsendiagnostics.com/both-delivery-models) - [Solutions](https://simsendiagnostics.com/solutions-overview) - [EVIDENCE](https://simsendiagnostics.com/evidence-hub) - [Publications](https://simsendiagnostics.com/evidence-publications) - [Paediatric solid tumours](https://simsendiagnostics.com/evidence-paediatric-solid-tumours) - [CNS tumours & CSF ctDNA](https://simsendiagnostics.com/evidence-cns-csf-ctdna) - [White papers](https://simsendiagnostics.com/evidence-white-paper-ctdna-trials) - [COMPANY](https://simsendiagnostics.com/company-about) - [About us](https://simsendiagnostics.com/company-about) - [Team](https://simsendiagnostics.com/company-team) - [Contact us](https://simsendiagnostics.com/company-contact) - [News](https://simsendiagnostics.com/news) - [RESOURCES](https://simsendiagnostics.com/resources-hub) - [Sample collection guides](https://simsendiagnostics.com/resources-sample-collection-guides) - [Baseline kit guide](https://simsendiagnostics.com/baseline-collection-kit) - [Follow-up kit guide](https://simsendiagnostics.com/resources-followup-collection-kit) [For clinical trials Pharma and CROs Validate MRD endpoints, cut trial-arm cost, build EU regulatory readiness. Design a trial assay →](https://simsendiagnostics.com/solutions-trials) [For research and labs Translational oncology See signal in paediatric and early-stage samples your current platform misses. Send samples or run SiMSen-Seq in-house. See the signal →](https://simsendiagnostics.com/solutions-research) [For clinics Premium oncology monitoring Detect minimal residual disease ahead of imaging. Logistics across the EU, UK and EEA. Detect relapse earlier →](https://simsendiagnostics.com/solutions-clinic) [Home](https://simsendiagnostics.com/) / [Company](https://simsendiagnostics.com/company-about) / [News](https://simsendiagnostics.com/news) / Simsen Diagnostics' hospital laboratory solution [← Back to all news](https://simsendiagnostics.com/news) Corporate Customer # Simsen Diagnostics' hospital laboratory solution By **Simsen** June 26, 2025, 12:43:00 PM GMT+02:00 1 min read ![](https://simsendiagnostics.com/hubfs/simsen-contact-scaled.jpg) We are proud to announce a new partnership with a Swedish hospital, paving the way for transformative advancements in personalised cancer care. This collaboration empowers hospital laboratories to implement efficient tumour-informed** circulating tumour DNA (ctDNA) analysis** with ease, precision, and minimal disruption to existing operations. Are you also seeking to **upgrade your laboratory’s cancer monitoring capabilities** while streamlining operations and reducing costs? Discover how you and Simsen Diagnostics can enable your team to deliver **personalised ctDNA analysis** with confidence. This solution is applicable to all hospital laboratories with access to a sequencer. **Personalised Panels – No In-House Development Required** - **No need to develop your own tumour-informed panels**: We design and supply patient-specific panels, enabling your lab to focus on high-quality ctDNA analysis. - **Accelerate time to implementation**: Skip lengthy development phases and start offering advanced monitoring faster. **Seamless Integration with Your Workflow** - **Sequencing-only solution**: If you have a sequencer, you’re ready to go. No major capital investments. - **Minimal workflow disruption**: Our protocols fit into your current lab infrastructure and clinical routines. **Knowledge Transfer and Support** - **Expert protocol transfer**: Your team receives hands-on knowledge and the latest ctDNA analysis methodologies from Simsen Diagnostics. - **Support**: Ongoing guidance ensures your lab operates at the highest standards of sensitivity and accuracy. **Fully Integrated Solutions** - **Comprehensive reagent kits**: All necessary reagents supplied for a robust workflow. - **Sample collection kits available**: For both tumour biopsies and plasma, simplifying logistics for your team. **Flexibility for Laboratory-Developed Tests (LDTs)** - **Retain control**: Use Simsen’s technology to develop your own LDTs, tailored to your patient population and institutional protocols. **Key Benefits for Hospital Laboratory Managers** - **Seamless adoption**: Integrate with your current sequencing platform. No new hardware required. - **Save time and resources**: Avoid costly and time-consuming panel development and validation. - **Stay ahead of the curve**: Access the latest protocols and scientific advances in ctDNA detection. - **Boost operational efficiency**: Unified supply of panels, reagents, and collection kits. - **Enhance clinical impact**: Provide clinicians and patients with earlier, more accurate detection of the tumour burden. - **Strengthen your lab’s reputation**: Position your laboratory as a leader in precision oncology, with personalised ctDNA analysis. **Join the Future of Cancer Monitoring** This partnership is just the first step. At Simsen Diagnostics, we **empower hospital laboratories **to deliver world-class, personalised cancer care, without compromise. **Ready to transform your cancer monitoring program?** Contact us today to learn how Simsen Diagnostics can help your laboratory become a leader in precision cancer monitoring. Send an email to [inbox@simsendiagnostics.com](mailto:inbox@simsendiagnostics.com) to discover how we can work together to save you time and money, and enhance your laboratory services. **Simsen Diagnostics – Personalised assays, personalised service.**   #### Share [mailto:?subject=Simsen+Diagnostics%27+hospital+laboratory+solution&body=https%3A%2F%2Fsimsendiagnostics.com%2Fnews%2Fsimsen-diagnostics-hospital-laboratory-solution](mailto:?subject=Simsen+Diagnostics%27+hospital+laboratory+solution&body=https%3A%2F%2Fsimsendiagnostics.com%2Fnews%2Fsimsen-diagnostics-hospital-laboratory-solution) #### On this page ## More from Simsen ### [June 16, 2026, 3:23:28 PM GMT+02:00 · Corporate Closing the gap between cancer research and patients is partly a question of where the test runs](https://simsendiagnostics.com/news/momentum2026-pre-event) ### [December 17, 2025, 11:57:23 AM GMT+01:00 · Corporate From more treatment to smarter treatment: how tumour‑informed ctDNA monitoring can reduce harm and free capacity in cancer care](https://simsendiagnostics.com/news/from-more-treatment-to-smarter-treatment-how-tumour-informed-ctdna-monitoring-can-reduce-harm-and-free-capacity-in-nordic-cancer-care) ### [November 17, 2025, 3:30:46 PM GMT+01:00 · Corporate Simsen Diagnostics Partners with One-carbon Therapeutics for Groundbreaking ODIN Cancer Trial](https://simsendiagnostics.com/news/simsen-diagnostics-partners-with-one-carbon-pharmaceuticals-for-groundbreaking-odin-cancer-trial) ### [November 11, 2025, 12:03:55 PM GMT+01:00 · Corporate How Pharma Companies Can Leverage Simsen Diagnostic’s Tumour-Informed ctDNA Analysis to Transform Cancer Drug Trials](https://simsendiagnostics.com/news/how-pharma-companies-can-leverage-simsen-diagnostics-tumour-informed-ctdna-analysis-to-transform-cancer-drug-trials) Talk to us ## Running a trial or service that needs this kind of signal? Tell us about your study and your endpoints. A real scientist in CET/CEST will reply. [Request a conversation](https://simsendiagnostics.com/start-a-conversation) [Back to all news](https://simsendiagnostics.com/news) ![full_lockup_white_CMYK kopia](https://simsendiagnostics.com/hs-fs/hubfs/full_lockup_white_CMYK%20kopia.png?width=166&height=45&name=full_lockup_white_CMYK%20kopia.png) **Visiting and postal address:** Pepparedsleden 1 431 53 Mölndal, Sweden **Shipping address:** c/o AstraZeneca R&D Mölndal Pepparedsleden 3 431 53 Mölndal, Sweden PLATFORM PLATFORM - [Platform overview](https://simsendiagnostics.com/platform) - [Why Simsen](https://simsendiagnostics.com/why-simsen) - [Our technology](https://simsendiagnostics.com/platform-our-technology) - [Delivered your way](https://simsendiagnostics.com/both-delivery-models) SOLUTIONS SOLUTIONS - [For clinical trials](https://simsendiagnostics.com/solutions-trials) - [For research and labs](https://simsendiagnostics.com/solutions-research) - [For clinics](https://simsendiagnostics.com/solutions-clinic) - [Solutions overview](https://simsendiagnostics.com/solutions-overview) COMPANY COMPANY - [About](https://simsendiagnostics.com/company-about) - [News](https://simsendiagnostics.com/news) - [Team](https://simsendiagnostics.com/company-team) - [Contact](https://simsendiagnostics.com/company-contact) - [Privacy policy](https://simsendiagnostics.com/legal-privacy-policy) - [Cookie Policy](https://simsendiagnostics.com/legal-cookie-policy) - [Terms of use](https://simsendiagnostics.com/legal-terms-of-use) © 2026 Simsen Diagnostics AB, All rights reserved. [Linkedin](https://www.linkedin.com/company/simsendiagnostics) Return to top ```json { "@context" : "https://schema.org", "@type" : "BlogPosting", "author" : { "@type" : "Person", "name" : "Simsen", "url" : "https://simsendiagnostics.com/news/author/simsen" }, "dateModified" : "2025-06-26T10:43:00.762Z", "datePublished" : "2025-06-26T10:43:00.000Z", "headline" : "Simsen Diagnostics' hospital laboratory solution", "image" : [ "https://simsendiagnostics.com/hubfs/simsen-contact-scaled.jpg" ], "mainEntityOfPage" : { "@id" : "https://simsendiagnostics.com/news/simsen-diagnostics-hospital-laboratory-solution", "@type" : "WebPage" }, "publisher" : { "@type" : "Organization", "logo" : { "@type" : "ImageObject", "url" : "https://simsendiagnostics.com/hubfs/SD_logo%20medium-2.png" }, "name" : "Simsen Diagnostics AB" } } ```